Early fast‐acting treatment strategy against generalized myasthenia gravisKimiaki Utsugisawa, Masashi Aoki, Hiroyuki Murai et al.|Muscle & Nerve|2016Cited by 75
A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in <i>CSF1R</i> masquerading as primary progressive multiple sclerosisBan‐yu Saitoh, Jun‐ichi Kira, Ryo Yamasaki et al.|Multiple Sclerosis Journal|2013Cited by 45
Response to treatment of myasthenia gravis according to clinical subtypeTetsuya Akaishi, Kimiaki Utsugisawa, Yasushi Suzuki et al.|BMC Neurology|2016Cited by 40
MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical typeTsuyoshi Hamaguchi, Masahito Yamada, Nobuo Sanjo et al.|Journal of Neurology Neurosurgery & Psychiatry|2020Cited by 25
Interleukin 2 receptor α chain gene polymorphisms and risks of multiple sclerosis and neuromyelitis optica in southern JapaneseGulibahaer Ainiding, Jun‐ichi Kira, Yuji Kawano et al.|Journal of the Neurological Sciences|2013Cited by 24